Russell Investments Group
KRON

Russell Investments Group’s Kronos Bio KRON Stock Holding History

Russell Investments Group’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,918
Closed -$17.1K – 3577
2023
Q2 		$17.1K Hold
9,918
– – ﹤0.01% 2867
2023
Q1 		$14.5K Buy
+9,918
New +$19K ﹤0.01% 2848

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group's KRON Position: Q3 2023 in Review

Russell Investments Group sold out of Kronos Bio (KRON) in Q3 2023, closing a stake of 9,918 shares — an estimated $17.1K sold.

Russell Investments Group first reported a position in KRON in Q1 2023 and held it in 2 quarters. The position peaked at $17.1K in Q2 2023. 63 funds tracked by Wall St. Rank hold KRON as of Q3 2023.

  • Russell Investments Group reported no remaining Kronos Bio position as of Q3 2023 after selling out during the quarter.
  • Russell Investments Group sold 9,918 Kronos Bio shares in Q3 2023, an estimated $17.1K.
  • Russell Investments Group first reported a position in Kronos Bio in Q1 2023 and held it in 2 quarters.
  • Russell Investments Group's Kronos Bio position peaked at $17.1K in Q2 2023.
  • 63 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2023.

Based on Russell Investments Group's 13F filing for Q3 2023, filed 13 Nov 2023.